Thermo Fisher Scientific PP&E (Net) increased by 0.9% to $10.66B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.2%, from $9.33B to $10.66B. Over 5 years (FY 2020 to FY 2025), PP&E (Net) shows an upward trend with a 12.3% CAGR.
An increase indicates ongoing capital investment in capacity, while a decrease may suggest aging assets or divestitures.
This represents the net book value of long-term tangible assets such as manufacturing facilities, laboratory equipment,...
High for manufacturing-heavy firms; lower for service-oriented or asset-light business models.
property_plant_equipment_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.56B | $7.05B | $8.33B | $8.45B | $8.53B | $8.63B | $9.28B | $9.35B | $9.29B | $9.17B | $9.45B | $9.32B | $9.28B | $9.41B | $9.31B | $9.33B | $9.64B | $10.18B | $10.57B | $10.66B |
| QoQ Change | — | +7.5% | +18.2% | +1.4% | +1.0% | +1.2% | +7.6% | +0.8% | -0.7% | -1.3% | +3.1% | -1.3% | -0.5% | +1.4% | -1.1% | +0.3% | +3.3% | +5.6% | +3.8% | +0.9% |
| YoY Change | — | — | — | — | +30.0% | +22.4% | +11.4% | +10.7% | +8.9% | +6.2% | +1.8% | -0.3% | -0.1% | +2.7% | -1.5% | +0.1% | +3.8% | +8.1% | +13.5% | +14.2% |
| Segment | Q4 '21 | Q4 '22 |
|---|---|---|
| All Other Countries | $4.29B | $4.57B |
| Total | $8.33B | $9.28B |